Skip to content
Home

Zika fever: causes, symptoms, complications, and prevention

Zika fever is a mosquito‑borne viral illness in the Flavivirus family. Usually mild or asymptomatic, it can cause birth defects and neurological complications; prevention focuses on mosquito control and travel guidance.

Author: Created: Updated:

Zika fever is an infectious disease caused by the Zika virus, a member of the Flavivirus group that also includes pathogens responsible for dengue and other mosquito‑borne illnesses. In most infected people the illness is mild or does not produce noticeable symptoms, but the virus attracted global attention after outbreaks in the Americas beginning in 2015 and because of its association with pregnancy complications and rare neurological disorders.

Image gallery

10 Images
Alexius Salvador Zika-Virus
simple.wikipedia.org · CC BY-SA 4.0

Typical course and symptoms

Following infection, many people (commonly estimated as a majority) experience no symptoms. When symptoms do occur they tend to be mild and short lived, typically developing within days of exposure and resolving within a week. Common findings include a low‑grade fever, conjunctivitis (red or irritated eyes), joint and muscle pain—often affecting the hands and feet—and a characteristic maculopapular rash that commonly starts on the face and spreads to the trunk and limbs. Fatigue and headache are also reported. Severe illness requiring hospitalization is uncommon in otherwise healthy adults.

Transmission, diagnosis and prevention

The virus is primarily transmitted by Aedes species mosquitoes, the same genus implicated in dengue and chikungunya transmission. Sexual transmission and vertical transmission from a pregnant person to the fetus have also been documented, which shaped public health recommendations during outbreaks. Laboratory diagnosis relies on detection of viral RNA by molecular tests in the early phase of illness or on serological tests for antibodies later on; cross‑reactivity with related flaviviruses can complicate interpretation.

There is no specific antiviral treatment for Zika fever. Management focuses on symptomatic care: rest, fluids, and analgesics or antipyretics as appropriate. Prevention emphasizes reducing mosquito exposure through environmental control (removing standing water, insecticide programs), personal protection (repellents, long sleeves, screens), and community public health measures. During periods of active transmission, health agencies have issued travel guidance and special precautions for pregnant people because of fetal risks.

Complications and public health significance

The most serious concern associated with Zika virus infection is its link to congenital abnormalities when infection occurs during pregnancy. Evidence gathered during the 2015–2016 outbreaks indicated an increased risk of microcephaly and other brain and developmental abnormalities in infants born to infected mothers. In adults, Zika infection has been associated with rare neurological conditions such as Guillain‑Barré syndrome, an autoimmune disorder that can cause muscle weakness and paralysis. These potential outcomes make surveillance, mosquito control, and clear clinical guidance priorities in affected regions.

Context, history and distinctions

First identified in Africa in the mid‑20th century, Zika virus remained relatively obscure until it caused large outbreaks in the Pacific and later in the Americas. Its relationship to other flaviviruses explains some shared clinical features and some diagnostic challenges. Unlike dengue, which can cause severe hemorrhagic disease, Zika is generally milder in presentation but carries distinct reproductive and neurological risks that influence public health responses.

Practical advice and resources

  • Seek medical advice if you develop fever, rash, conjunctivitis, or joint pain after travel to an area with Zika transmission.
  • Pregnant people or those trying to conceive should consult healthcare providers about travel and testing options in areas with active transmission.
  • Use proven mosquito‑avoidance measures and support community mosquito control programs to reduce local transmission risk.

Further reading and official sources

This article summarizes widely reported information about Zika fever for general reference. For clinical decisions, pregnancy counseling, or up‑to‑date travel advisories consult local public health authorities or designated clinical guidelines.

Questions and answers

Q: What is Zika fever?

A: Zika fever is an illness caused by the Zika virus, which belongs to the genus Flavivirus.

Q: What are the symptoms of Zika fever?

A: Most people who get the virus (60-80%) have no symptoms, but those who do usually experience a low fever, conjunctivitis, joint pain (mainly in hands and feet), and a rash that starts on the face and spreads to the rest of the body. Symptoms usually last 2-7 days.

Q: When did an outbreak of Zika virus occur in Brazil?

A: An outbreak of Zika virus began in Brazil in 2015.

Q: How can pregnant women be affected by the Zika virus?

A: Scientists think that when a woman with the Zika virus is pregnant, she can give it to her fetus, which can cause microcephaly--a birth defect that causes a baby to have a smaller head than usual and can lead to intellectual disability and other brain problems like seizures.

Q: What countries should pregnant women avoid due to risk of getting infected with the Zika Virus?

A: Pregnant women should avoid traveling to Brazil, Colombia, El Salvador, French Guiana, Guatemala, Haiti, Honduras, Martinique Mexico Panama Paraguay Suriname Venezuela or Puerto Rico due to risk of getting infected with the Zika Virus.

Q: Are there any other risks associated with living in areas where there is active transmission of the Zika Virus?

A: In places where there is active transmission of the Zika Virus people may be more likely to have birth defects neurological problems like Guillain-Barré syndrome and autoimmune diseases.

Related articles

Author

AlegsaOnline.com Zika fever: causes, symptoms, complications, and prevention

URL: https://en.alegsaonline.com/art/110598

Share

Sources